August 1

BioMS Medical completes patient recruitment in phase III U.S. multiple sclerosis trial

BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that it has completed patient recruitment in its phase III clinical trial of MBP8298 (dirucotide) for the treatment of secondary progressive MS (SPMS). The trial, named MAESTRO-03, includes approximately 510 patients, and is being conducted at 68 trial sites in the U.S.

\"We have had great success in recruiting patients into the trial, which is a testament to the promise of our approach and the efforts of our investigators,\" said Mr. Kevin Giese, President and CEO. \"Since initiating this trial in June 2007 we have been delighted by the enthusiasm of the patients and clinical groups participating across the U.S.\" Read more: BioMS Medical Corp ( MS )

August 1

Addax Petroleum announces Federal Government Approval of Nigeria Gas Utilisation Initiative

International consortium formed for investment in gas development - including the potential monetization of OML137 gas

Addax Petroleum Corporation (TSX: AXC and LSE: AXC) (\"Addax Petroleum\" or the \"Corporation\"), together with its partners Chrome Oil Services Limited (\"Chrome\") and Korea Gas Corporation (\"KOGAS\"), announces today that it has received the approval from the Federal Government of Nigeria, for its proposed implementation of an integrated gas utilization project in Nigeria. Addax Petroleum has also entered into a heads of agreement with Chrome, a leading Nigerian oil and gas company, and KOGAS, South Korea\'s national gas company, forming an international consortium (the \"Consortium\") which, upon finalization of the necessary project development agreements, will take responsibility for the development of this integrated gas utilization project in response to the Nigerian Government\'s current gas marketing master plan. Read more: Addax Petroleum Corporation ( AXC )

August 1

Peet\'s Coffee & Tea, Inc. Reports 62% Increase in Second Quarter 2008 Diluted Earnings Per Share

Peet\'s Coffee & Tea, Inc. (Nasdaq: PEET) today announced its results for the quarter ended June 29, 2008, which included 13 weeks.

In this release, the Company reports:

-- Net revenue of $70.1 million, an increase of 17% versus last year;
-- Diluted earnings per share of $0.21, an increase of 62% versus last year; and
-- The Company added 300 additional grocery accounts in the quarter and Peet\'s is now available in 7,200 grocery stores, on track for a full year target of 8,000. Read more: Peet\'s Coffee & Tea Inc ( PEET )

Agentek Expands Field Service Management with Real-Time Workforce Optimization from 360 Scheduling

Nottingham, UK, 1st August, 2008 - Agentek, Inc., a leading mobile field service software provider, today announced Agentek Workforce Optimization, a dynamic routing and scheduling optimization solution powered by a partnership with 360 Scheduling, the leading workforce scheduling engine.

Escalating fuel prices, unexpected repairs, high maintenance costs, traffic delays and rescheduling issues all erode field service profits. Agentek’s new offering of street-level routing, time-of-day travel calculations and turn-by-turn direction capabilities reduce fuel expense, minimize travel, and maximize the field force productive time with customers. Read more: Agentek Expands Field Service Management with Real-Time Workforce Optimization